Objectives-To prospectively evaluate the diagnostic performance of 3-dimensional (3D) shear wave elastography (SWE) for assessing thyroid nodules.
T he incidence of thyroid nodules is high in the general population, and 5% to 15% of thyroid nodules are malignant. 1, 2 High-resolution ultrasound (US) has played a key role in detecting thyroid nodules, whereas it is challenging to discriminate malignant from benign nodules. 3 Many risk stratification systems, [4] [5] [6] [7] [8] [9] [10] including the Thyroid Imaging Reporting and Data System (TI-RADS) proposed by Kwak et al, 6 have been introduced into clinical practice, which provide effective malignancy risk stratification for thyroid nodules by applying several US characteristics. 11, 12 However, nearly all the TI-RADSs have the limitation of low specificity. To improve the diagnostic specificity, US elastography has recently emerged as a novel noninvasive and adjunctive method in addition to conventional US by evaluating the tissue stiffness. Tissue stiffness increases in thyroid malignancy, particularly for papillary thyroid carcinoma, which is the most common type of thyroid cancer. 3 Shear wave elastography (SWE) has been widely considered as a quantitative, reproducible, and operatorindependent technique among various kinds of elastographic techniques. Shear wave elastography uses the radiation force emitted from the US transducer, generates shear waves in tissues, and tracks the propagation of shear waves using pulse-echo US to estimate the shear wave propagation speed. The shear wave propagation speed is quantitatively correlated with the local viscoelastic properties of tissue. Shear wave elastography displays the measurements of elasticity indices as the Young modulus (in kilopascals) and shear wave velocity (in meters per second). Many studies have showed that the quantitative elasticity indices on 2-dimensional (2D) SWE are markedly different between benign and malignant thyroid nodules, which improve the diagnostic specificity. 3, 13 Three-dimensional (3D) SWE is a more recent development of SWE, which provides 3D quantitative elasticity maps of the entire thyroid nodule and surrounding tissue. In comparison with 2D SWE, 3D SWE may provide more comprehensive information on thyroid nodules. It facilitates display of images in the coronal plane that is parallel to transducer surface, which is hardly achievable with 2D SWE. In addition, the stiffness distribution in thyroid nodules is always heterogeneous, particularly for thyroid malignancy. The stiffness heterogeneity in thyroid nodules may be better evaluated with 3D SWE because it provides volume data for stiffness that covers the whole nodule, whereas only sectional images are available for 2D SWE.
Three-dimensional SWE has shown promise for breast tumor diagnosis and is valuable for treatment monitoring of breast lesions under chemotherapy. [14] [15] [16] On the other hand, to our best knowledge, all previous SWE studies on the thyroid were performed with 2D SWE, 1, 3, 17, 18 and no studies have been conducted to investigate the diagnostic performance of 3D SWE for thyroid nodules. To answer the question of whether 3D SWE is helpful in clinical practice, this prospective study was performed with the aim of evaluating the diagnostic performance of 3D SWE in predicting thyroid nodule malignancy.
Materials and Methods

Patients
Approval from the Ethics Committee of the university hospital was obtained for this study, and all patients who participated in this study provided informed consent. From October 2016 to January 2017, we prospectively studied the thyroid nodules in 306 consecutive patients using conventional US, 2D SWE, and 3D SWE before US-guided fine-needle aspiration (FNA) or surgery in a tertiary hospital. The inclusion criteria for the patients were as follows: (1) thyroid nodules of 10 mm or larger; (2) solid nodules or nodules with mixed components (cystic portion < 75%) [19] [20] [21] ; and (3) nodule nature confirmed by histopathologic examination after surgery. For those with benign FNA cytologic results, at least 6 months of follow-up was needed, and changes in the size and US features were observed. When patients had multiple thyroid nodules, the most suspicious nodule was selected. For those without suspicious US features, the largest thyroid nodule was selected. 6, 10 Totally, 179 patients with 179 nodules were enrolled. The exclusion criteria were as follows: (1) invasive procedure such as radiofrequency ablation for the nodule (n 5 1); and (2) incomplete image data (n 5 2). Finally, the study group consisted of 176 patients with 176 thyroid nodules ( Figure 1 ).
Conventional US, 2D SWE, and 3D SWE Examinations Conventional US, 2D SWE, and 3D SWE examinations were implemented by 1 of 3 board-certified radiologists, each had at least 1 year of experience with the Aixplorer US elastographic system (SuperSonic Imagine, Aix-enProvence, France). All radiologists were subject to training with at least 30 cases of data acquisition and 2D and 3D SWE measurement before the formal study. The interval was less than 1 minute between conventional US, 2D SWE, and 3D SWE examinations.
All of the patients lay on the bed in the supine position, with slight dorsal flexion of their heads. Conventional US images were obtained with a 50-mm, 15-4-MHz linear array transducer for each target nodule transversely and longitudinally. After the conventional US examination, transverse and longitudinal 2D SWE images for each thyroid nodule were obtained with the same transducer. The transducer was kept perpendicular to the skin with minimal compression: a generous amount of US gel was used to ensure good acoustic coupling. To obtain a 2D SWE map, a good grayscale US image was acquired first. Patients were required to hold their breath or swallow for a few seconds during SWE acquisition. The SWE color image was acquired by placing a sampling box adjusted to contain the thyroid nodule and some surrounding tissue. The Young modulus was used to represent the tissue elasticity, and the elasticity range was set from 0 (blue, soft) to 100 (red, stiff) kPa. The 2D SWE map was displayed along with the grayscale US image in a split-screen mode to help locate the target nodule.
Afterward, 3D SWE was performed with an SLV 16-5 transducer. The 3D transducer was carefully placed on the neck surface with compression as minimal as possible. During the 3D SWE data acquisition, the transducer was kept still for about 10 seconds. Serial 2D SWE images were obtained, and 3D volumetric SWE data were then formed and reconstructed. The multiplanar orthogonal mode (transverse, sagittal, and coronal views) was used for subsequent analysis.
On 2D and 3D SWE images, quantitative elasticity values were estimated with the use of 2 circular regions of interest (ROIs) for all the nodules by the same radiologist. The rules for ROI placement were as follows: (1) one large circular ROI was placed to cover the nodule as large as possible, while another 2-mm ROI was placed on the stiffest region on the basis of the color stiffness map; (2) internal or peripheral calcifications were deliberately avoided; (3) cystic areas were avoided; (4) areas without SWE color coding were avoided; and (5) no surrounding tissues were included in the ROI. Then mean elasticity (E_mean), standard deviation of elasticity (E_SD), and maximum elasticity (E_max) of the large ROI were measured, as well as the E_mean of the 2-mm ROI. For 3D SWE, 2D images of the lesion in 3 orthogonal views were thoroughly reviewed slice by slice, and the view with the highest stiffness was used to measure the 4 above-mentioned SWE parameters on the basis of color stiffness map.
Image Evaluation
For conventional US images, the suspicious US characteristics were defined according to the TI-RADS of Kwak et al 6 as follows: solid component, microlobulated or irregular margin, hypoechogenicity or marked hypoechogenicity, taller-than-wide shape, and microcalcifications or mixed calcifications. The nodules with no suspicious US characteristics were categorized as TI-RADS category 3, whereas the nodules with 1, 2, 3 or 4, and 5 suspicious US characteristics were categorized as TI-RADS categories 4a, 4b, 4c, and 5, respectively. Both US images and TI-RADS categories were retrospectively analyzed by 2 skillful radiologists with consensus.
Four quantitative SWE parameters were calculated and recorded for each nodule: (1) E_mean in the large ROI, (2) E_SD in the large ROI, (3) E_max in the large ROI, and (4) E_mean in the 2-mm ROI placed over the stiffest portion. The E_mean in the large ROI and E_mean in the 2-mm ROI represented the averages of the shear wave values in the large ROI and the 2-mm ROI, which were calculated and displayed on the screen automatically.
Reference Standard
The reference standard for the final diagnosis of the thyroid nodules was either the histopathologic result after surgery or cytologic examination after FNA in combination with follow-up. Ultrasound-guided FNA was decided in accordance with the TI-RADS criteria of Kwak et al 6 and the latest American Thyroid Association (ATA) guidelines. 10 In general, FNA was recommended for thyroid nodules of TI-RADS category 4a or higher, whereas for most of category 3 or lower, follow-up was recommended. In addition, for some nodules without suspicious features, if the criteria for FNA recommendation were met by the ATA guidelines, FNA was also recommended. However, nodules with spongiform or almost completely cystic appearances, which were typical benign features, were not recommended for FNA. Fineneedle aspiration was performed in all nodules with a 22-gauge needle and a 5-mL syringe. The cytologic reports were classified by 1 of 3 thyroid cytopathologists with more than 3 years of experience based on the Bethesda System for Reporting Thyroid Cytopathology. 22 For thyroid malignancy, the histopathologic result after surgery was the only reference standard, even though the FNA results were Bethesda category V or VI. For benign nodules, either the histopathologic result after surgery or the cytological result after FNA in combination with follow-up was accepted as the reference standard. For those nodules (ie, Bethesda category II), no changes in the size and US features for at least 6 months were needed. If the nodules showed a greater than 20% increase in at least 2 dimensions or 50% growth in volume or showed new suspicious US features in follow-up, repeated FNA was recommended. 23 In our center, according to the ATA guidelines, we recommended repeated FNA, a molecular marker test, or diagnostic surgery for nodules in categories I, III, and IV, depending on the suspicious US features, whereas for Bethesda category V nodules, surgical management is recommended. 10 Interoperator and Intraoperator Reproducibility of 2D and 3D SWE Thirty consecutive patients with 30 thyroid nodules who did not participate in the diagnostic performance analysis study were enrolled for the test of the interoperator consistency of 2D and 3D SWE, which were performed on the same day by 2 independent operators with the same experience in SWE. Another 30 consecutive patients with 30 nodules were evaluated for the intraoperator consistency of 2D and 3D SWE. These examinations were repeated by the same operator with a 1-day interval.
Statistical Analyses
Statistical analyses were conducted with SPSS version 22.0 software (IBM Corporation, Armonk, NY) and MedCalc version 15.2 software (MedCalc, Mariakerke, Belgium). Statistical tests were considered statistically significant at 2-tailed P < .05. Comparisons of the differences in quantitative elasticity values between benign and malignant thyroid nodules as well as between 2D and 3D SWE were performed by an independent 2-sample t test or a paired t test. In addition, a comparison of the categorical variables was analyzed by the v 2 test. In a receiver operating characteristic curve analysis, the area under the curve (AUC) was computed to evaluate the diagnostic performance, and the method of DeLong et al 24 was used to compare AUCs among conventional US, 2D SWE, and 3D SWE. When the Youden index achieved the maximum, the cutoff value was acquired from the receiver operating characteristic curve, as well as the corresponding sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV). The McNemar test was used to compare the differences in sensitivity and specificity. The intraclass correlation coefficient was used for evaluating the interoperator and intraoperator reproducibility. The intraclass correlation coefficient values were classified as follows: 0 to 0.20, poor agreement; 0.20 to 0.40, fair agreement; 0.40 to 0.60, moderate agreement; 0.60 to 0.80, strong agreement; and greater than 0.80, excellent agreement. 25 
Results
Final Diagnosis
Of the 176 thyroid nodules, 113 were benign and 63 were malignant (Figure 1 ). Among them, 36 benign nodules and 63 malignant nodules were confirmed by surgery. The remaining 77 benign nodules were confirmed by benign FNA results in combination with follow-up. None of them grew or showed new suspicious US features on follow-up. Of the 36 surgically confirmed benign nodules, 21 were nodular goiters; 8 were Hashimoto nodules; 5 were adenomatous goiters; 1 was a follicular adenoma; and 1 was an oncocytic adenoma. Of the 63 surgically confirmed malignant nodules, 59 were papillary thyroid carcinomas; 3 were follicular carcinomas; and 1 was a medullary carcinoma.
Basic and US Characteristics
The 176 patients in the study group included 142 women and 34 men (mean age 6 SD, 50.2 6 13.6 years; range, 20-82 years). The mean nodule was 17.8 6 9.0 mm (range, 10-56 mm). Table 1 lists a summary of demographic and US features. Patient sex was not associated with thyroid malignancy (P 5 .054). Patients with benign nodules were older than those with malignant nodules (P 5 .037). The size of benign nodules was significantly larger than that of malignant ones (P 5 .001). Ultrasound features, such as a solid component, a microlobulated or irregular margin, hypoechogenicity or marked hypoechogenicity, a taller-than-wide shape, and microcalcifications or mixed calcifications, were more frequently found in malignant nodules than in benign ones (all P < .05).
The distribution of nodules in each US TI-RADS category is listed in Table 2 . The malignant rates for TI-RADS categories 3, 4a, 4b, 4c, and 5 were 3.6% (1 of 28), 5.4% (2 of 37), 15.2% (5 of 33), 64.4% (41 of 64), and 100% (14 of 14), respectively.
Quantitative Elasticity Parameters on 2D and 3D SWE The elasticity parameters of the 176 thyroid nodules are summarized in Table 3 and Figure 2 . Malignant nodules showed higher elasticity values than benign nodules on both 2D and 3D SWE (all P < .001).
With respect to the comparison between 2D and 3D SWE, E_max and E_SD on 3D SWE were higher than those on 2D SWE (59. Diagnostic Performances of Conventional US, 2D SWE, and 3D SWE The diagnostic performances of conventional US, 2D SWE, and 3D SWE in predicting thyroid malignancy are displayed in Table 4 and Figures 3-5 . Figure 2 . Box-and-whisker plots of 4 SWE parameters on 2D and 3D SWE for benign and malignant thyroid nodules. Central bars represent the median, box tops and bottoms denote upper and lower quartiles, and whiskers denote the range excluding outliers (a value larger than the upper quartile plus 1.5 times the interquartile range or smaller than the lower quartile minus 1.5 times the interquartile range). Data are presented as mean 6 SD.
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Nodules of TI-RADS category 4a or higher were considered to have positive results, whereas those of category 3 or lower were considered to have negative results. This stratification was just for the purpose of measuring the performance of TI-RADS compared with the reference standard. The AUC for conventional US by TI-RADS category was 0.612 (95% confidence interval [CI], 0.529-0.694), with corresponding sensitivity of 98.4% (62 of 63), specificity of 23.9% (27 of 113), PPV of 41.9% (62 of 148), and NPV of 96.4% (27 of 28).
As for 2D SWE, the optimal cutoff values for E_mean, E_max, and E_SD of the large ROI were 26, 49.5, and 8.3 kPa, respectively. The cutoff value for E_mean of the 2-mm ROI was 40.6 kPa. The associated AUCs were 0.819 (95% CI, 0.754-0.873), 0.836 (95% CI, 0.773-0.888), 0.818 (95% CI, 0.753-0.872), and 0.816 (95% CI, 0.751-0.870). Maximum elasticity showed the highest AUC in comparison with other 2D SWE parameters; however, there were no statistically significant differences among the 2D SWE parameters. Conventional US (A) shows a predominately solid and isoechoic nodule, which is 11.8 mm in diameter and is classified as TI-RADS category 3. Both 2D (A) and 3D (B) SWE show a homogeneously soft (blue) nodule with maximum elasticity of 14 kPa on 2D SWE and elasticity SD of 5.1 kPa on 3D SWE.The cytologic result (C) shows that the nodule is benign. For E_max, sensitivity of 74.6%, specificity of 82.3%, NPV of 85.3%, and PPV of 70.1%, were achieved. As for 3D SWE, the optimal cutoff values for E_mean, E_max, and E_SD of the large ROI were 18.4, 69.2, and 13 kPa, respectively. The cutoff value for E_mean of the 2-mm ROI was 46.8 kPa. The associated AUCs were 0.792 (95% CI, 0.724-0.849), 0.804 (95% CI, 0.738-0.860), 0.839 (95% CI, 0.776-0.890), and 0.823 (95% CI, 0.759-0.877), respectively. Among the 3D SWE parameters, the AUC of E_SD was the highest, which was significantly higher than that of E_max (P 5 .048) and E_mean (P 5 .038) of the large ROI, but did not show a significant difference in comparison with the AUC of E_mean of the 2-mm ROI (P > .05). With an optimal cutoff value of 13 kPa, E_SD achieved sensitivity of 74.6%, specificity of 88.5%, NPV of 86.2%, and PPV of 78.3%.
No significant difference was found between the AUC of E_SD on 3D SWE and the AUC of E_max on 2D SWE (0.839 versus 0.836; P > .05). In addition, the difference in the AUC between 2D and 3D SWE was not statistically significant for E_mean (0.819 versus 0.792; P 5 .486), E_max (0.836 versus 0.804; P 5 .145), and E_SD (0.818 versus 0.839; P 5 .562) of the large ROI, as well as E_mean of the 2-mm ROI (0.816 versus 0.823; P 5 .742). Nevertheless, 3D SWE could increase the specificity in comparison with 2D SWE (88.5% versus 82.3%; P 5 .039). Both 2D and 3D SWE increased the diagnostic performance significantly in comparison with conventional US (both P < .001).
Role of 2D and 3D SWE in Reducing Unnecessary FNA A subset of nodules with low suspicion on conventional US (ie, TI-RADS category 4a; n 5 37) were used to study whether SWE could decrease unnecessary FNA procedures on benign nodules. For 2D SWE, we downgraded TI-RADS category 4a nodules to category 3 by applying E_max of 49.5 kPa or less as the threshold; 77.1% (27 of 35) of benign category 4a nodules were successfully downgraded to category 3, and FNA was not necessary.
For 3D SWE, we downgraded TI-RADS category 4a nodules to category 3 by applying E_SD of 13 kPa or less as the threshold; 88.6% (31 of 35) of benign category 4a nodules were successfully downgraded to category 3. Thus, in comparison with 2D SWE, 3D SWE successfully avoided unnecessary FNA in an additional 11.5% of category 4a nodules.
Both 2D and 3D SWE misdiagnosed a malignant nodule, which showed a solid component on conventional US. Its histopathologic result after surgery was follicular carcinoma.
Interoperator and Intraoperator Consistency of 2D and 3D SWE The correlation coefficients for E_max on 2D SWE were 0.821 (95% CI, 0.657-0.910) for interoperator consistency and 0.907 (95% CI, 0.814-0.955) for intraoperator consistency. In addition, the correlation coefficients of E_SD on 3D SWE were 0.841 (95% CI, 0.693-0.921) for interoperator consistency and 0.917 (95% CI, 0.834-0.960) for intraoperator consistency.
Discussion
In this study, the quantitative SWE values in malignant thyroid nodules were all significantly higher than those in benign nodules on both 2D and 3D SWE, which were consistent with previous studies. 1, 3, 17, 18 These results indicate that both 2D and 3D stiffness distributions provide clues for the diagnosis of thyroid nodules.
Maximum elasticity max on 3D SWE was significantly higher than that on 2D SWE, which is concordant with the finding in previous literature on the breast. 14, 15 One possible reason is that 3D SWE provides a more comprehensive evaluation of the nodule than 2D SWE and thus has a higher chance of finding the stiffest region within the nodule. For example, the stiffest region may be detected in the coronal plane of 3D SWE, which is hard to obtain with 2D SWE. Some authors also indicated that the coronal plane was advantageous in showing infiltration of thyroid cancer. 26, 27 Another possible reason may be transducer compression, which increases Figure 5 . Malignant nodule in a 42-year-old woman. Conventional US (A) shows a solid hypoechoic nodule with a poor margin and microcalcifications, which is 19.5 mm in diameter and is classified as TI-RADS category 5. Both 2D (A) and 3D (B) SWE show a heterogeneously stiff (red and yellow) nodule with maximum elasticity of 119.6 kPa on 2D SWE and elasticity SD of 34.6 kPa on 3D SWE. The histopathologic result after surgery shows that the nodule is papillary thyroid carcinoma (C). the tissue stiffness. 28 A heavier convex 3D transducer might cause a higher degree of compression than a 2D linear transducer, which in turn increases the stiffness measurement of E_max. This factor should be taken into consideration when interpreting the measurement results with 3D SWE, since it is hard to be avoided completely. In this study, nodules with a cystic component as large as 74% would have been included. This factor would not have affected the SWE parameters, since the cystic areas were avoided deliberately when placing the ROI. Even if small cystic portions were included, they would not have been color coded because shear waves do not propagate in fluid. The noncoded areas are not included for computation of SWE parameters.
Mean elasticity of the large ROI on 2D SWE was higher than that on 3D SWE, whereas E_mean of the 2-mm ROI did not show a significant difference between 2D and 3D SWE in this present study. This finding would indicate that E_mean of the 2-mm ROI was more consistent on both 2D and 3D SWE. The underlying reason for this phenomenon is unclear. It could be caused by the difference in ROI selection: 2D SWE provided a B-mode image to assist ROI selection, whereas 3D SWE did not, or it could be caused by the different transducers used for 2D and 3D SWE acquisitions. Chang et al 29 also documented that different transducers can yield different SWS values in the liver. One would think that E_max of the large ROI and E_mean of the 2-mm ROI would both have identified the stiffest part of the nodule, assuming that the operator placed the latter ROI appropriately. In fact, there are still some slight differences. Maximum elasticity indicates the maximum elasticity value in the large ROI, whereas E_mean of the 2-mm ROI indicates the mean elasticity value in the 2-mm ROI region, which may include the maximum elasticity value. In the study, we observed that there were differences between E_max of the large ROI and E_mean of the 2-mm ROI. However, there was no significant difference between E_max of the large ROI and E_mean of the 2-mm ROI in diagnostic performance on both 2D and 3D SWE.
For 2D SWE, E_max was the best among the 4 SWE parameters in predicting thyroid malignancy, even though no significant differences were found among different SWE parameters, which was consistent with other studies using 2D SWE. 30, 31 Bhatia et al 18 reported that compared with E_mean and E_SD, E_max had the best diagnostic performance in 2D SWE. He et al 31 found
that the AUC of E_max was the highest among the 3 SWE parameters in 2D SWE (0.799), with the cutoff value (42.9 kPa), sensitivity (63.8%), specificity (88.2%), PPV (73.2%), and NPV (82.8%). These results suggested that E_max may be the most useful parameter for thyroid nodule diagnosis with 2D SWE. For 3D SWE, however, E_SD showed the best performance among the 4 SWE parameters. This measurement indicates the stiffness heterogeneity in the nodule, which is useful for differentiating benign from malignant thyroid lesions. 18, 31 Bhatia et al 18 reported that when E_SD was used as a surrogate indicator of heterogeneity, malignant thyroid nodules showed significantly higher heterogeneity than benign nodules. Tian et al 15 found that E_SD showed better diagnostic accuracy compared with E_max on 3D SWE for differentiating malignant from benign breast lesions. Therefore, for 3D SWE, E_SD, rather than E_max or E_mean, should be applied for differentiation between malignant and benign thyroid nodules. This measure of nodule heterogeneity makes sense not only for solid nodules but also for mixed cystic and solid ones, since the cystic areas are avoided when the ROI is placed.
It is not surprising that no significant difference in diagnostic performance was found between 2D and 3D SWE in terms of the AUC. However, 3D SWE had higher specificity (88.3% versus 82.3%) in comparison with 2D SWE. The increased specificity is meaningful in clinical practice, which is helpful for excluding negative cases.
In this study, the TI-RADS suggested by Kwak et al 6 was applied to stratify the malignancy risk of thyroid nodules on US imaging. This system was selected because it is easy to use and convenient for clinical practice. In addition, Yoon et al 11 found that both the TI-RADS of Kwak et al 6 and the ATA guidelines 10 provided effective malignancy risk stratification for thyroid nodules. In a comparative study of 6 guidelines for small thyroid nodules, Yoon et al 12 found that the sensitivity and NPV were the highest for the TI-RADS of Kwak et al. 6 In a comparative study of 4 TI-RADSs in surgically resected nodules, Wang et al 32 also found that with its higher sensitivity, the TI-RADS of Kwak et al 6 was convenient and practical for the management of thyroid nodules in clinical practice. The malignancy rate of each category in this study was consistent with that of Kwak et al, 6 suggesting the universe applicability of this TI-RADS for the Eastern Asian population. The TI-RADS achieved high sensitivity of 98.4% but low specificity of 23.9% in this study. The low specificity led to many unnecessary FNA procedures. In this study, a subset of nodules with low suspicion on conventional US (ie, TI-RADS category 4a) were used to study whether SWE could decrease unnecessary FNA procedures on benign nodules. It is interesting that 2D SWE was able to avoid unnecessary FNA procedures in 77.1% of benign category 4a nodules. Moreover, with the help of 3D SWE, unnecessary FNA procedures were avoided in an additional 11.5% of benign category 4a nodules; thus, 88.6% of unnecessary FNA procedures were avoided. These results indicate that 3D SWE has a substantial role in decision making for management of thyroid nodules.
Several studies have indicated that SWE is operator independent.
21,31, 33 He et al 31 reported that 2D SWE was a highly reproducible technique, with correlation coefficients of 0.846 for interoperator consistency and 0.946 for intraoperator consistency. Our study also showed good interoperator and intraoperator consistency for 2D and 3D SWE. To our knowledge, this study was the first to confirm excellent reproducibility of 3D SWE for diagnosis of thyroid nodules. The intraclass correlation coefficient values for 3D SWE were 0.841 for interoperator consistency and 0.917 for intraoperator consistency, indicating that 3D SWE is a reproducible technology for assessing thyroid tissue stiffness.
There were several limitations in this study. First, a selection bias may have been present because patients enrolled in that study were referred for FNA or thyroid surgery. This population might not be representative of a normal screening population. Second, long-term US follow-up data for benign findings on FNA were not available in our study. In the study, none of the Bethesda category II nodules grew or showed new suspicious US features on follow-up; thus, they were considered benign. Some groups advocate repeated FNA for Bethesda category II nodules that have a suspicious US appearance. Therefore, there might have been falsenegative cases; however, the false-negative rate for a nodule with a benign finding on FNA is less than 3% 22 ; thus, the influence of this factor can be reduced to a minimum. Third, the influence of Hashimoto thyroiditis on stiffness was not evaluated in this study. Forth, a large round ROI was applied in this study, which might not have encompassed the entire nodule, especially for an ellipsoid or irregular nodule. However, a round ROI is convenient and easy to place, which is more acceptable in clinical practice. Furthermore, the results for US units from various vendors may be different. It is unknown whether the results in this study could be generalizable to other vendors' equipment; thus, further comparative studies with various vendors' equipment are needed. In addition, although 2D and 3D SWE perform well in reducing unnecessary FNA, they take more time and are not popular in comparison with conventional US. In a practical sense, given that risk stratification systems based on conventional greyscale US already perform well in identifying high-risk nodules, it would make sense to reserve SWE for lesser-risk nodules with the hope of doing fewer FNAs on them. Finally, the study was a single-center study and did not include sufficient cases. Larger multicenter studies are needed to confirm the findings.
In summary, both 2D and 3D SWE increase the diagnostic performance in comparison with conventional US. Three-and two-dimensional SWE showed similar diagnostic performance in detecting malignant thyroid nodules, whereas the specificity was increased for 3D SWE. Two-dimensional SWE reduces unnecessary FNA procedures in thyroid nodules with low suspicion of malignancy, and 3D SWE further enhances this role. Three-dimensional SWE showed good reproducibility, with high interoperator and intraoperator consistency.
